Esters Having The -s(=o)(=o)-s- Group, Wherein The Divalent Sulfur Is Bonded Directly To Carbon, Which Carbon May Be Single Bonded To Any Atom But May Be Multiple Bonded Only To Carbon (e.g., Thiolsulfonate Esters, Etc.) Patents (Class 560/307)
  • Patent number: 10494336
    Abstract: Disclosed are monomers for copolymerization with alkenes, dienes, vinyl compounds, and/or vinylidene compounds, a process for preparing a copolymer, a copolymer prepared by the process, a sulfur-crosslinkable rubber mixture, and the use of the sulfur-crosslinkable rubber mixture for production of motor vehicle tires. In one embodiment, the monomer has the formula A-S—P, wherein A is a chemical group containing at least one C?C aliphatic double bond, S is a sulfur atom, and P is a protecting group.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: December 3, 2019
    Assignee: Continental Reifen Deutschland GmbH
    Inventors: Katharina Herzog, Lena Mueller, Carla Recker, Noa Pruss, Cathrin Sonja Conrad, Phillipp Vana
  • Publication number: 20140194610
    Abstract: Described herein are methods for the synthesis of derivatives of thiosulfonate reagents. Said reagents have utility for the synthesis of phosphorothiotriesters from H-phosphonates in a stereospecific fashion.
    Type: Application
    Filed: July 13, 2012
    Publication date: July 10, 2014
    Inventors: Gregory L. Verdine, Meena Meena, Naoki Iwamoto, David Charles Donnell Butler
  • Patent number: 8450390
    Abstract: The present invention provides both crosslinked polymer compositions capable of forming hydrogels upon exposure to an aqueous environment and thiosulfonate hydrogel-forming components. The thiosulfonate hydrogel-forming components of the invention are preferably multi-arm thiosulfonate polymer derivatives that form a crosslinked polymer composition when exposed to a base without requiring the presence of a second cross-linking reagent, redox catalyst, or radiation. Methods for forming hydrogel compositions, as well as methods for using the hydrogels, are also provided.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: May 28, 2013
    Assignee: Nektar Therapeutics
    Inventors: Zhihao Fang, Michael D. Bentley
  • Publication number: 20130096278
    Abstract: The object of the present invention is to provide a novel thiosulfonate compound, a reversible cationization agent for protein and/or peptide, which can reversibly cationize a wider range of proteins and peptides with high stability of quality and accuracy and which are useful for a high degree of purification and recovery, as well as, a method for solubilization for protein and/or peptide using the agent. The present invention is a thiosulfonate compound having three or more cations derived from a quaternary ammonium group within one molecule.
    Type: Application
    Filed: March 24, 2011
    Publication date: April 18, 2013
    Applicant: NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
    Inventors: Junichiro Futami, Hidenori Yamada, Go Kyuragi, Keiichiro Yagi
  • Patent number: 8247598
    Abstract: The present invention provides both crosslinked polymer compositions capable of forming hydrogels upon exposure to an aqueous environment and thiosulfonate hydrogel-forming components. The thiosulfonate hydrogel-forming components of the invention are preferably multi-arm thiosulfonate polymer derivatives that form a crosslinked polymer composition when exposed to a base without requiring the presence of a second cross-linking reagent, redox catalyst, or radiation. Methods for forming hydrogel compositions, as well as methods for using the hydrogels, are also provided.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: August 21, 2012
    Assignee: Nektar Therapeutics
    Inventors: Zhihao Fang, Michael D. Bentley
  • Patent number: 8097695
    Abstract: The present invention provides both crosslinked polymer compositions capable of forming hydrogels upon exposure to an aqueous environment and thiosulfonate hydrogel-forming components. The thiosulfonate hydrogel-forming components of the invention are preferably multi-arm thiosulfonate polymer derivatives that form a crosslinked polymer composition when exposed to a base without requiring the presence of a second cross-linking reagent, redox catalyst, or radiation. Methods for forming hydrogel compositions, as well as methods for using the hydrogels, are also provided.
    Type: Grant
    Filed: August 25, 2009
    Date of Patent: January 17, 2012
    Assignee: Nektar Therapeutics
    Inventors: Zhihao Fang, Michael D. Bentley
  • Publication number: 20100004424
    Abstract: The present invention provides both crosslinked polymer compositions capable of forming hydrogels upon exposure to an aqueous environment and thiosulfonate hydrogel-forming components. The thiosulfonate hydrogel-forming components of the invention are preferably multi-arm thiosulfonate polymer derivatives that form a crosslinked polymer composition when exposed to a base without requiring the presence of a second cross-linking reagent, redox catalyst, or radiation. Methods for forming hydrogel compositions, as well as methods for using the hydrogels, are also provided.
    Type: Application
    Filed: August 25, 2009
    Publication date: January 7, 2010
    Applicant: Nektar Therapeutics
    Inventors: Zhihao Fang, Michael D. Bentley
  • Patent number: 7078551
    Abstract: A blocked mercaptosilane of the structure: G-C(?O)—S—CH2CH2CH2SiX3 is disclosed wherein each X is an independently selected RO— group or R— group wherein each R is independently selected from the group consisting of hydrogen, alkyl that may or may not contain unsaturation, alkenyl groups, aryl groups, and aralkyl groups, such moieties other than hydrogen having from 1 to 18 carbon atoms, at least one X is RO—, and G is a monovalent alkyl group.
    Type: Grant
    Filed: April 30, 2004
    Date of Patent: July 18, 2006
    Assignee: General Electric Company
    Inventors: Richard W. Cruse, Robert J. Pickwell, Eric Raymond Pohl, Keith J. Weller
  • Patent number: 7074876
    Abstract: Disclosed herein is a blocked mercaptosilane selected from the group consisting of [[(ROC(?O))p—(G)j]k—Y—S]r—G—(SiX3)s; and??(1) [(X3Si)q—G]a—[Y—[S—G—SiX3]b]c??(2) wherein Y is a polyvalent species (Q)zA(?E) selected from the group consisting of —C(?NR)—; —SC(?NR)—; —SC(?O)—; —OC(?O)—; —S(?O)—; —S(?O)2—; —OS(?O)2—; (—NR)S(?O)2—; —SS(?O)—; —OS(?O)—; (—NR)S(?O)—; —SS(?O)2—; (—S)2P(?O)—; —(—S)P(?O)—; —P(?O)(—)2; (—S)2P(?S)—; —(—S)P(?S)—; —P(?S)(—)2; (—NR)2P(?O)—; (—NR)(—S)P(?O)—; (—O)(—NR)P(?O)—; (—O)(—S)P(?O)—; (—O)2P(?O)—; —(—O)P(?O)—; —(—NR)P(?O)—; (—NR)2P(?S)—; (—NR)(—S)P(?S)—; (—O)(—NR)P(?S)—; (—O)(—S)P(?S)—; (—O)2P(?S)—; —(—O)P(?S)—; and —(—NR)P(?S)—; wherein the atom A attached to unsaturated heteroatom E is attached to the sulfur which in turn is linked via a group G to the silicon atom; each R is chosen independently from hydrogen, straight, cyclic, or branched alkyl that may or may not contain unsaturation, alkenyl groups, aryl groups, and aralkyl groups, with each R containing from 1 to 18 c
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: July 11, 2006
    Assignee: General Electric Company
    Inventors: Richard W. Cruse, Robert J. Pickwell, Keith J. Weller, Eric R. Pohl
  • Patent number: 6608125
    Abstract: A blocked mercaptosilane of the structure: G—C(═O)—S—CH2CH2CH2SiX3 is disclosed wherein each X is an independently selected RO— group wherein each R is independently selected from the group consisting of hydrogen, alkyl that may or may not contain unsaturation, alkenyl groups, aryl groups, and aralkyl groups, such moieties other than hydrogen having from 1 to 18 carbon atoms, and G is a monovalent alkyl of from 2 to 12 carbon atoms.
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: August 19, 2003
    Assignee: Crompton Corporation
    Inventors: Richard W. Cruse, Robert J. Pickwell, Keith J. Weller, Eric R. Pohl
  • Patent number: 5510518
    Abstract: Process for the preparation of olefins by using a palladium catalyst at a temperature above the ceiling temperature of the SO.sub.2 /olefin copolymer system, for the synthesis of sulfinic and sulfonic acid derivatives.
    Type: Grant
    Filed: September 1, 1994
    Date of Patent: April 23, 1996
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Jurgen K. Herwig, Wilhelm Keim
  • Patent number: 5124348
    Abstract: A compound of Formula (I):R.sup.1 (CA.dbd.CA.sup.1).sub.x --C(.dbd.X)NR.sup.2 R.sup.3 (I)where R.sup.1 is alkyl optionally substituted by a group selected from alkoxy, alkenyl, alkynyl, alkenyloxy, alkynyloxy, aryl, aryloxy, arylalkoxy and cycloalkyl fused to an aryl ring; x=1 or 2; X=O or S; each A and A.sup.1 is independently hydrogen, alkyl or haloalkyl; R.sup.2 is alkyl, alkenyl or cycloalkyl any of which may be substituted by halo, alkenyl, alkyl, cycloalkyl, alkynyl, dioxalanylalkyl or alkoxy; and R.sup.3 is selected from groups (A) to (D):(A) --Y.dbd.X.sup.1 --(R.sup.4).sub.a where X.sup.1 is O or S, Y is phosphorus or carbon, R.sup.4 is hydrogen, alkyl, alkoxy, acyl or CO.sub.2 R.sup.5 where R.sup.5 is alkyl or aryl, and a is 1 or 2(B) --S(R.sup.6)(O).sub.b where R.sup.6 is alkyl, aryl, aryloxy, alkoxy, thioalkoxy, thioaryl, alkythio, alkoxythio or arylthio and b is 0, 1 or 2(C) --S(O).sub.c NR.sup.7 R.sup.8 where c is 0, 1 or 2, R.sup.7 is --COR.sup.9 or --CO.sub.2 R.sup.9 where R.sup.
    Type: Grant
    Filed: May 17, 1991
    Date of Patent: June 23, 1992
    Assignee: Burroughs Wellcome Co.
    Inventors: Malcolm H. Black, Robert J. Blade, Robert J. Peek
  • Patent number: 4992578
    Abstract: Alkyl alkanethiolsulfonates are prepared by oxidation of the corresponding alkanethiol, dialkyl disulfide, or mixture thereof by aqueous hydrogen peroxide in the presence of a Group VIII transition metal catalyst.
    Type: Grant
    Filed: March 9, 1990
    Date of Patent: February 12, 1991
    Assignee: Atochem North America, Inc.
    Inventor: Altaf Husain
  • Patent number: 4910331
    Abstract: This invention relates to a process for producing a thiolsulfonic acid derivative of the general formula: ##STR1## wherein each of R.sub.1 and R.sub.2 is independently a lower alkyl group or a 5- or 6-membered cycloalkyl group, or alternatively R.sub.1 and R.sub.2 together with the adjacent nitrogen atom form a 5- or 6-membered heterocyclic group which may further contain an oxygen, sulfur or nitrogen atom; and R.sub.3 is (1) an aryl group which may optionally be substituted by a lower alkyl group, a halogen, a lower alkoxy group or a lower alkylthio group, (2) a lower alkyl group which may optionally be substituted by a lower alkoxy group, (3) an aralkyl group or (4) a cycloalkyl group, or a salt thereof, which comprises reacting a compound of the general formula: ##STR2## wherein R.sub.1 and R.sub.2 are as defined above, or a salt thereof with a compound of the general formula:R.sub.3 SO.sub.2 H (II)wherein R.sub.3 is as defined above, or a salt thereof under an acid condition.
    Type: Grant
    Filed: October 7, 1988
    Date of Patent: March 20, 1990
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Kazuaki Kihara, Makoto Kuroda, Toshiyuki Nakamura
  • Patent number: 4879249
    Abstract: Novel immunoassay which utilizes an enzyme linked ligand or receptor wherein the enzyme is bacterial luciferase; mercantile kit useful in performing said immunoassay; and compounds utilized in performing said assay.
    Type: Grant
    Filed: March 17, 1986
    Date of Patent: November 7, 1989
    Inventors: Thomas O. Baldwin, Thomas F. Holzman, Paul S. Satoh, Frederick S. Yein